Michael David Dake MD, Presenter: Scientific Advisory Board, W. L. Gore & Associates, Inc Scientific Advisory Board, Abbott Laboratories Scientific Advisory Board, TriVascular, Inc Research Consultant, Cook Group Incorporated Research support, Cook Group Incorporated Consultant, Medtronic, Inc

1) Understand the current applications of thoracic endografts for management of thoracic aortic pathologies. 2) Recognize the benefits and existing limitations of current endograft technologies for treatment of different aortic lesions. 3) Identify the complications and failure modes of TEVAR. 4) Know the current outcome metrics typically evaluated after TEVAR treatment of thoracic aneurysms and aortic dissections. 5) List the important imaging findings and criteria currently used to assess the suitability of aortic anatomy for TEVAR.

Dake, M, TEVAR Indications and Outcomes.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/13011999.html